Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Related Citations for PubMed (Select 19818678)

1.

Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus.

Falsey AR, Formica MA, Walsh EE.

J Clin Virol. 2009 Dec;46(4):314-7. doi: 10.1016/j.jcv.2009.09.020. Epub 2009 Oct 8.

2.

Humoral immunity to human metapneumovirus infection in adults.

Falsey AR, Hennessey PA, Formica MA, Criddle MM, Biear JM, Walsh EE.

Vaccine. 2010 Feb 10;28(6):1477-80. doi: 10.1016/j.vaccine.2009.11.063. Epub 2009 Dec 8.

3.

Expeditious neutralization assay for human metapneumovirus based on a recombinant virus expressing Renilla luciferase.

Zhou M, Kitagawa Y, Yamaguchi M, Uchiyama C, Itoh M, Gotoh B.

J Clin Virol. 2013 Jan;56(1):31-6. doi: 10.1016/j.jcv.2012.09.014. Epub 2012 Oct 16.

PMID:
23084005
4.

[Analysis of neutralizing activity of sera from 0 to 6 years old children in Chongqing area against human metapneumovirus].

Zhang Q, Yang XQ, Zhao XD.

Zhonghua Er Ke Za Zhi. 2007 Jun;45(6):432-6. Chinese.

PMID:
17880789
5.

Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults.

Okamoto M, Sugawara K, Takashita E, Muraki Y, Hongo S, Nishimura H, Matsuzaki Y.

J Med Virol. 2010 Dec;82(12):2092-6. doi: 10.1002/jmv.21920.

PMID:
20981798
6.

Experimental infection of adults with recombinant wild-type human metapneumovirus.

Talaat KR, Karron RA, Thumar B, McMahon BA, Schmidt AC, Collins PL, Buchholz UJ.

J Infect Dis. 2013 Nov 15;208(10):1669-78. doi: 10.1093/infdis/jit356. Epub 2013 Aug 1.

7.

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.

Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR.

J Virol. 2004 Jul;78(13):6927-37.

8.

Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.

Alvarez R, Harrod KS, Shieh WJ, Zaki S, Tripp RA.

J Virol. 2004 Dec;78(24):14003-11.

9.

A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Schuster JE, Cox RG, Hastings AK, Boyd KL, Wadia J, Chen Z, Burton DR, Williamson RA, Williams JV.

J Infect Dis. 2015 Jan 15;211(2):216-25. doi: 10.1093/infdis/jiu307. Epub 2014 May 26.

PMID:
24864121
10.

A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE Jr, Williamson RA.

J Virol. 2007 Aug;81(15):8315-24. Epub 2007 May 23.

11.

An improved plaque reduction virus neutralization assay for human metapneumovirus.

de Graaf M, Herfst S, Schrauwen EJ, van den Hoogen BG, Osterhaus AD, Fouchier RA.

J Virol Methods. 2007 Aug;143(2):169-74. Epub 2007 Apr 8.

PMID:
17420056
12.

Immunofluorescence assay for detection of human metapneumovirus-specific antibodies by use of baculovirus-expressed fusion protein.

Ishiguro N, Ebihara T, Endo R, Ma X, Shirotsuki R, Ochiai S, Ishiko H, Kikuta H.

Clin Diagn Lab Immunol. 2005 Jan;12(1):202-5.

13.

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.

Corti D, Bianchi S, Vanzetta F, Minola A, Perez L, Agatic G, Guarino B, Silacci C, Marcandalli J, Marsland BJ, Piralla A, Percivalle E, Sallusto F, Baldanti F, Lanzavecchia A.

Nature. 2013 Sep 19;501(7467):439-43. doi: 10.1038/nature12442. Epub 2013 Aug 18.

PMID:
23955151
14.

T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.

Kolli D, Bataki EL, Spetch L, Guerrero-Plata A, Jewell AM, Piedra PA, Milligan GN, Garofalo RP, Casola A.

J Virol. 2008 Sep;82(17):8560-9. doi: 10.1128/JVI.00699-08. Epub 2008 Jun 18.

15.
16.

[Seroprevalence of antibody against human metapneumovirus in Beijing].

Zhao LQ, Cao SC, Zhu RN, Li GH, Deng J, Wang F, Jia LP, Qian Y.

Zhonghua Er Ke Za Zhi. 2005 Dec;43(12):904-7. Chinese.

PMID:
16412351
17.

Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.

Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE Jr, Williams JV.

J Virol. 2007 Jan;81(2):698-707. Epub 2006 Oct 18.

18.

Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice.

Lévy C, Aerts L, Hamelin MÈ, Granier C, Szécsi J, Lavillette D, Boivin G, Cosset FL.

Vaccine. 2013 Jun 7;31(25):2778-85. doi: 10.1016/j.vaccine.2013.03.051. Epub 2013 Apr 11.

PMID:
23583815
19.

Generation of recombinant metapneumovirus nucleocapsid protein as nucleocapsid-like particles and development of virus-specific monoclonal antibodies.

Petraitytė-Burneikienė R, Nalivaiko K, Lasickienė R, Firantienė R, Emužytė R, Sasnauskas K, Zvirblienė A.

Virus Res. 2011 Nov;161(2):131-9. doi: 10.1016/j.virusres.2011.07.009. Epub 2011 Jul 30.

PMID:
21827798
20.

Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China.

Lu G, Gonzalez R, Guo L, Wu C, Wu J, Vernet G, Paranhos-Baccalà G, Wang J, Hung T.

Virol J. 2011 Feb 10;8:62. doi: 10.1186/1743-422X-8-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk